Skip to content

Author

I. García-Lunar

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Empagliflozin attenuates pulmonary vascular hemodynamic progression and improves right ventricular adaptation in overcirculation-induced pulmonary hypertension

Right ventricular (RV) failure is the principal determinant of prognosis in pulmonary arterial hypertension (PAH). While current therapies primarily target pulmonary vasoconstriction and vascular remodeling, no treatment directly addresses RV maladaptation. Sodium–glucose cotransporter-2 (SGLT2) inhibitors exert...

C. Real, I. García-Lunar, E. Sandoval et al. · 0 citations
Aug 2026

Prevalence of Silent Atherosclerosis across Adult Life.

This study of silent atherosclerosis showed that the disease was detectable in early adulthood, with age- and sex-associated increases in prevalence across arterial territories and marked increases in plaque volume.

H. Bundgaard, I. García-Lunar, K. F. Kofoed et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.